What is Pipeline Rx?
Pipeline Rx operates at the intersection of clinical expertise and digital innovation, providing a comprehensive suite of telepharmacy services designed to optimize pharmacy operations. The company's core offerings include clinical telepharmacy, transitions of care, and advanced patient therapy management systems. By integrating these services into surgery centers and long-term care facilities, Pipeline Rx addresses the complex logistical challenges faced by modern healthcare providers. Their market position is defined by a dual focus on enhancing operational throughput and improving clinical outcomes, effectively reducing costs for health systems while maintaining high standards of medication safety and quality care.
How much funding has Pipeline Rx raised?
Pipeline Rx has raised a total of $18.6M across 4 funding rounds:
Private Equity
$2.4M
Other Financing Round
$5M
Private Equity
$9.2M
Debt
$2M
Private Equity (2014): $2.4M with participation from AMN Healthcare Services
Other Financing Round (2014): $5M led by AMN Healthcare
Private Equity (2015): $9.2M supported by McKesson, AMN Healthcare, and Mitsui & Co. (U.S.A.), Inc.
Debt (2020): $2M featuring PPP
Key Investors in Pipeline Rx
McKesson
A global leader in pharmaceutical distribution and healthcare technology, providing integrated supply chain and clinical solutions to hospitals and health systems.
AMN Healthcare
A premier provider of total talent solutions for the healthcare industry, specializing in recruitment and workforce management strategies.
Mitsui & Co. (U.S.A.), Inc.
A diversified global trading and investment firm with a strategic focus on enhancing quality of life through healthcare solutions and infrastructure development.
What's next for Pipeline Rx?
With the recent influx of capital, Pipeline Rx is well-positioned to accelerate its strategic initiatives, focusing on the expansion of its digital pharmacy footprint and the refinement of its patient therapy management platforms. The company's growth trajectory, supported by a history of private equity and debt financing, suggests a shift toward deeper integration within large-scale health systems. Future efforts will likely prioritize the deployment of automated dispensing technologies and the scaling of clinical support services to meet the rising demand for remote pharmacy oversight. As the healthcare landscape continues to prioritize cost-efficiency and patient safety, Pipeline Rx remains a pivotal player in the evolution of institutional medication management.
See full Pipeline Rx company page
